Literature DB >> 28490753

WBC count predicts the risk of new-onset peripheral arterial disease in a Chinese community-based population.

Yuxi Li1, Fangfang Fan1, Jia Jia1, Jianping Li1, Yong Huo1, Yan Zhang1.   

Abstract

This longitudinal cohort study investigated whether peripheral WBC counts could predict peripheral arterial disease (PAD) incidence after a 2.3-year follow-up in a Chinese community-based population without PAD at baseline. A total of 3555 Chinese subjects without fever and PAD at baseline from an atherosclerosis cohort were included in our analysis. The ankle brachial index (ABI) was measured, and PAD was defined as an ABI <0.9. Multivariate regression models were used to evaluate the association of WBC count and new-onset PAD. The mean (±s.d.) baseline WBC count was 6.11±1.54 × 109 l-1, the mean (±s.d.) ABI was 1.11±0.08 at baseline and the incidence of PAD was 2.7% over 2.3 years. WBC counts were significantly associated with PAD incidence (odds ratio (OR)=1.27, 95% confidence interval (CI): 1.14-1.41, P<0.0001) with every 1 × 109 l-1 increase in WBC count. This relationship remained significant (OR=1.21, 95% CI: 1.08-1.36, P=0.0014) even after adjusting for other variables. The highest WBC quartile group had increased risk when compared with the lowest quartile group (OR=2.14, 95% CI: 1.09-4.22, P=0.027) in a multivariate logistic model. Furthermore, we did not find significant heterogeneity among the analyzed subgroups based on sex (male or female), age (<60 or ⩾60 years old), body mass index (BMI, <25 or ⩾25 kg m-2), current smoking, current drinking, hypertension, diabetes mellitus, dyslipidemia or cardiovascular disease. In conclusion, elevated WBC counts independently predict the risk of new-onset PAD in a Chinese community-based population, supporting the hypothesis that systemic inflammation plays an important role in PAD development.

Entities:  

Mesh:

Year:  2017        PMID: 28490753     DOI: 10.1038/hr.2017.64

Source DB:  PubMed          Journal:  Hypertens Res        ISSN: 0916-9636            Impact factor:   3.872


  23 in total

1.  White blood cell count: an independent predictor of coronary heart disease mortality among a national cohort.

Authors:  D W Brown; W H Giles; J B Croft
Journal:  J Clin Epidemiol       Date:  2001-03       Impact factor: 6.437

2.  Relationship of monocyte count and peripheral arterial disease: results from the National Health and Nutrition Examination Survey 1999-2002.

Authors:  Khurram Nasir; Eliseo Guallar; Ana Navas-Acien; Michael H Criqui; João A C Lima
Journal:  Arterioscler Thromb Vasc Biol       Date:  2005-06-23       Impact factor: 8.311

3.  Mortality over a period of 10 years in patients with peripheral arterial disease.

Authors:  M H Criqui; R D Langer; A Fronek; H S Feigelson; M R Klauber; T J McCann; D Browner
Journal:  N Engl J Med       Date:  1992-02-06       Impact factor: 91.245

4.  The leukocyte count as a predictor of myocardial infarction.

Authors:  G D Friedman; A L Klatsky; A B Siegelaub
Journal:  N Engl J Med       Date:  1974-06-06       Impact factor: 91.245

5.  Risk of myocardial infarction and angina in patients with severe peripheral vascular disease: predictive role of C-reactive protein.

Authors:  Elisabetta Rossi; Luigi M Biasucci; Franco Citterio; Simona Pelliccioni; Claudia Monaco; Francesca Ginnetti; Dominick J Angiolillo; Gianni Grieco; Giovanna Liuzzo; Attilio Maseri
Journal:  Circulation       Date:  2002-02-19       Impact factor: 29.690

6.  Prevalence of and risk factors for peripheral arterial disease in the United States: results from the National Health and Nutrition Examination Survey, 1999-2000.

Authors:  Elizabeth Selvin; Thomas P Erlinger
Journal:  Circulation       Date:  2004-07-19       Impact factor: 29.690

7.  Noninvasive Central Systolic Blood Pressure Is More Strongly Related to Kidney Function Decline Than Peripheral Systolic Blood Pressure in a Chinese Community-Based Population.

Authors:  Fangfang Fan; Litong Qi; Jia Jia; Xin Xu; Yan Liu; Yang Yang; Xianhui Qin; Jianping Li; Haixia Li; Yan Zhang; Yong Huo
Journal:  Hypertension       Date:  2016-05-02       Impact factor: 10.190

Review 8.  Current therapies and investigational drugs for peripheral arterial disease.

Authors:  Jun-Ichi Suzuki; Munehisa Shimamura; Hiroyuki Suda; Kouji Wakayama; Hidetoshi Kumagai; Yuichi Ikeda; Hiroshi Akazawa; Mitsuaki Isobe; Issei Komuro; Ryuichi Morishita
Journal:  Hypertens Res       Date:  2015-12-03       Impact factor: 3.872

9.  Biomarkers of inflammation and thrombosis as predictors of near-term mortality in patients with peripheral arterial disease: a cohort study.

Authors:  Himabindu Vidula; Lu Tian; Kiang Liu; Michael H Criqui; Luigi Ferrucci; William H Pearce; Philip Greenland; David Green; Jin Tan; Daniel B Garside; Jack Guralnik; Paul M Ridker; Nader Rifai; Mary M McDermott
Journal:  Ann Intern Med       Date:  2008-01-15       Impact factor: 25.391

10.  Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013.

Authors: 
Journal:  Lancet       Date:  2014-12-18       Impact factor: 79.321

View more
  1 in total

1.  Monocyte subtype counts are associated with 10-year cardiovascular disease risk as determined by the Framingham Risk Score among subjects of the LIFE-Adult study.

Authors:  Samira Zeynalova; Karolin Bucksch; Markus Scholz; Maryam Yahiaoui-Doktor; Melanie Gross; Markus Löffler; Susanne Melzer; Attila Tárnok
Journal:  PLoS One       Date:  2021-03-01       Impact factor: 3.240

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.